Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

February 6, 2018

Study Completion Date

February 6, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Vortioxetine

Vortioxetine tablet

Trial Locations (25)

2190

Coastal Research Associates, Inc., South Weymouth

2740

Novex Clinical Research, LLC, New Bedford

10023

Columbia University Medical Center, New York

19446

Green & Seidner Family Practice Associates, Lansdale

32806

Compass Research Main, Orlando

33162

Behavioral Clinical Research , Inc, North Miami

33613

University of South Florida, Tampa

34652

Suncoast Clinical Research Inc., New Port Richey

45406

Dayton Clinical Research, Dayton

48109

University of Michigan, Ann Arbor, Ann Arbor

60563

Baber Research Group, Naperville

60640

Great Lakes Clinical Trials, Chicago

75243

Relaro Medical Trials, Dallas

77090

Red Oak Psychiatry Associates, PA, Houston

77381

Family Psychiatry of The Woodlands, The Woodlands

78229

Radiant Research, Inc., San Antonio

80910

MCB Clinical Research Centers, LLC, Colorado Springs

90230

ProScience Research Group, Culver City

91206

Behavioral Research Specialists, LLC, Glendale

91207

University Medical Group, Upland

92056

Excell Research, Oceanside

92374

Anderson Clinical Research, Redlands

92626

ATP Clinical Research, Inc., Costa Mesa

94607

Pacific Research Partners, Oakland

47713-1227

Deaconess Clinic, Evansville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY